Worldwide distribution of prekallikrein (PK) deficiency: the defect seems mainly concentrated in West African countries and in the United States Worldwide distribution of PK deficiency:
Main Article Content
Keywords
Downloads
Download data is not yet available.
Abstract 677
PDF Downloads 154
HTML Downloads 108
References
1. Hathaway WE, Belhasen LP, Hathaway HS. Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood. 1965;26:521-532. https://doi.org/10.1182/blood.V26.5.521.521 PMid:5845778
2. Hathaway WE, Wuepper KD, Weston WL, Humbert JR, Rivers RP, Genton E, August CS, Montgomery RR, Mass MF. Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency. Am J Med. 1976;60:654-664. https://doi.org/10.1016/0002-9343(76)90500-3
3. Girolami A, Scarparo P, Candeo N, Lombardi AM. Congenital prekallikrein deficiency. Expert Rev Hematol. 2010;3:685-595. https://doi.org/10.1586/ehm.10.69 PMid:21091145
4. Sollo DG, Saleem A. Prekallikrein (Fletcher factor) deficiency. Ann Clin Lab Sci. 1985;15:279-285.5. Girolami A, Ferrari S, Cosi E, Girolami B. The high prevalence of Prekallikrein deficiency among African Americans deserves further
studies. Hematol Med Oncol. 2020;5:1-2. https://doi.org/10.15761/HMO.1000201
6. Girolami A, Ferrari S, Cosi E, Girolami B. Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United
States. Clin Appl Thromb Hemost. 2020;26:1-3. https://doi.org/10.1177/1076029620918301 PMid:32243188 PMCid:PMC7288793
7. Essien EM, Ebhota MI. Fletcher Factor Deficiency - Detection of a Severe Case in a Population Survey. Acta Haematol. 1977;58:353-358. https://doi.org/10.1159/000207849 PMid:413313
8. Adenaeuer A, Ezigbo ED, Nazir HF, Barco S, Trinchero A, Laubert?Reh D, Strauch K, Wild PS, Lackner KJ, Lämmle B, Rossmann H.c. 451dupT in KLKB1 is common in Nigerians, confirming a higher
prevalence of severe prekallikrein deficiency in Africans compared to Europeans. J Thrombo Hemostas. 2020.
https://doi.org/10.1111/jth.15137 PMid:33073460
9. Dasgupta SK, Rivera S, Thiagarajan P. Lisinopril-Induced Angioedema in a Patient with Plasma Prekallikrein Deficiency. TH Open. 2020;4:e33-e35. https://doi.org/10.1055/s-0040-1701238 PMid:31984307 PMCid:PMC6978173
10. Mendy VL, Vargas R, Payton M, Sims JN, Zhang L. Trends in the Stroke Death Rate Among Mississippi Adults, 2000-2016. Prev Chronic Dis. 2019. 14;16:E21. https://doi.org/10.5888/pcd16.180425 PMid:30767859 PMCid:PMC6395077
11. Colantonio LD, Monda KL, Rosenson RS, Brown TM, Mues KE, Howard G, Safford MM, Yedigarova L, Farkouh ME, Muntner P. Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial
Inclusion Criteria. Cardiovasc Drugs Ther. 2019;33:189-199. https://doi.org/10.1007/s10557-019-06864-2
PMid:30746585 PMCid:PMC6917479
12. Waldron FA, Benenson I, Jones-Dillon SA, Zinzuwadia SN, Adeboye AM, Eris E, Mbadugha NE, Vicente N, Over A. Prevalence and risk factors for hypertensive crisis in a predominantly African American inner-city community. Blood Press. 2019;28:114-123. https://doi.org/10.1080/08037051.2019.1568183 PMid:30669866
2. Hathaway WE, Wuepper KD, Weston WL, Humbert JR, Rivers RP, Genton E, August CS, Montgomery RR, Mass MF. Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency. Am J Med. 1976;60:654-664. https://doi.org/10.1016/0002-9343(76)90500-3
3. Girolami A, Scarparo P, Candeo N, Lombardi AM. Congenital prekallikrein deficiency. Expert Rev Hematol. 2010;3:685-595. https://doi.org/10.1586/ehm.10.69 PMid:21091145
4. Sollo DG, Saleem A. Prekallikrein (Fletcher factor) deficiency. Ann Clin Lab Sci. 1985;15:279-285.5. Girolami A, Ferrari S, Cosi E, Girolami B. The high prevalence of Prekallikrein deficiency among African Americans deserves further
studies. Hematol Med Oncol. 2020;5:1-2. https://doi.org/10.15761/HMO.1000201
6. Girolami A, Ferrari S, Cosi E, Girolami B. Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United
States. Clin Appl Thromb Hemost. 2020;26:1-3. https://doi.org/10.1177/1076029620918301 PMid:32243188 PMCid:PMC7288793
7. Essien EM, Ebhota MI. Fletcher Factor Deficiency - Detection of a Severe Case in a Population Survey. Acta Haematol. 1977;58:353-358. https://doi.org/10.1159/000207849 PMid:413313
8. Adenaeuer A, Ezigbo ED, Nazir HF, Barco S, Trinchero A, Laubert?Reh D, Strauch K, Wild PS, Lackner KJ, Lämmle B, Rossmann H.c. 451dupT in KLKB1 is common in Nigerians, confirming a higher
prevalence of severe prekallikrein deficiency in Africans compared to Europeans. J Thrombo Hemostas. 2020.
https://doi.org/10.1111/jth.15137 PMid:33073460
9. Dasgupta SK, Rivera S, Thiagarajan P. Lisinopril-Induced Angioedema in a Patient with Plasma Prekallikrein Deficiency. TH Open. 2020;4:e33-e35. https://doi.org/10.1055/s-0040-1701238 PMid:31984307 PMCid:PMC6978173
10. Mendy VL, Vargas R, Payton M, Sims JN, Zhang L. Trends in the Stroke Death Rate Among Mississippi Adults, 2000-2016. Prev Chronic Dis. 2019. 14;16:E21. https://doi.org/10.5888/pcd16.180425 PMid:30767859 PMCid:PMC6395077
11. Colantonio LD, Monda KL, Rosenson RS, Brown TM, Mues KE, Howard G, Safford MM, Yedigarova L, Farkouh ME, Muntner P. Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial
Inclusion Criteria. Cardiovasc Drugs Ther. 2019;33:189-199. https://doi.org/10.1007/s10557-019-06864-2
PMid:30746585 PMCid:PMC6917479
12. Waldron FA, Benenson I, Jones-Dillon SA, Zinzuwadia SN, Adeboye AM, Eris E, Mbadugha NE, Vicente N, Over A. Prevalence and risk factors for hypertensive crisis in a predominantly African American inner-city community. Blood Press. 2019;28:114-123. https://doi.org/10.1080/08037051.2019.1568183 PMid:30669866
Article Sidebar
Published
Jan 1, 2021
Article Details
How to Cite
Girolami, A. and Ferrari, S. (2021) “Worldwide distribution of prekallikrein (PK) deficiency: the defect seems mainly concentrated in West African countries and in the United States: Worldwide distribution of PK deficiency:”, Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. e2021014. doi: 10.4084/mjhid.2021.014.
Issue
Section
Letters to the Editor
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
Author Biography
Silvia Ferrari, Università di Padova, Dipartimento di Medicina
Dipartimento di Medicina